Literature DB >> 16138594

[Asthma epidemiology].

Isabella Annesi-Maesano1.   

Abstract

Asthma is excessively common among the individuals (up to 10% in adults and 35% in children). Asthma is differently distributed in the world. Asthma incidence is 1%/y in average. Children are at greater risk of asthma than adults, which could be due to a cohort effect. Severe asthma is reported by 1-3% of the general population (children and adults respectively). Recent population-based data show that the asthma prevalence increase observed worldwide in the past 30 years has now stopped in industrialised countries. Such phenomenon has been paralleled by an increase in the use of asthma medications. The development and phenotypic expression of asthma depends on a complex interaction between genetic and environmental factors. Gene-environment interactions already in early life should be explored to understand asthma epidemiological evolution.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138594

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  3 in total

1.  Identification of anti-asthmatic compounds in Pericarpium citri reticulatae and evaluation of their synergistic effects.

Authors:  Qian Shi; Ze Liu; Yang Yang; Peng Geng; Yuan-yuan Zhu; Qi Zhang; Fang Bai; Gang Bai
Journal:  Acta Pharmacol Sin       Date:  2009-04-13       Impact factor: 6.150

2.  Preventive Effect of Novel Bacterial Polysaccharide and Animal Splenic Protein as Natural Adjuvants on Animal Model of Asthma.

Authors:  Majid Mirsadraee; Saleh Mohaghegh Hazrati; Mohammad Reza Khakzad; Kamran Ghafarzadegan; Mohhamad Hosein Boskabady
Journal:  Iran J Basic Med Sci       Date:  2012-09       Impact factor: 2.699

3.  In Vivo Evaluation of the Antiasthmatic, Antitussive, and Expectorant Activities and Chemical Components of Three Elaeagnus Leaves.

Authors:  Yuebin Ge; Fei Zhang; Qin Qin; Yingying Shang; Dingrong Wan
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-21       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.